Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

5H-Pyrido[3,2-a]phenoxazine-3-carboxylicacid, 1-hydroxy-5-oxo-, sodium salt (1:1)

Related Products

Hot Products

Basic Information Post buying leads Suppliers
Name

5H-Pyrido[3,2-a]phenoxazine-3-carboxylicacid, 1-hydroxy-5-oxo-, sodium salt (1:1)

EINECS 257-181-6
CAS No. 51410-30-1 Density 1.7g/cm3
PSA 116.35000 LogP 0.91010
Solubility N/A Melting Point N/A
Formula C16H7N2NaO5 Boiling Point 515.8 °C at 760 mmHg
Molecular Weight 330.2269 Flash Point 265.7 °C
Transport Information N/A Appearance N/A
Safety Risk Codes N/A
Molecular Structure Molecular Structure of 51410-30-1 (1-HYDROXY-5-OXO-5H-PYRIDO[3,2-A]PHENOXAZINE-3-CARBOXYLIC ACID MONOSODIUM SALT) Hazard Symbols N/A
Synonyms

5H-Pyrido[3,2-a]phenoxazine-3-carboxylicacid, 1-hydroxy-5-oxo-, monosodium salt (9CI);Catalin sodium;Pirenoxinesodium;Pirfenoxone sodium salt;Sodium1-hydroxy-5-oxo-5H-pyrido[3,2-a]phenoxazine-3-carboxylate;sodium 1,5-dioxo-1,5-dihydro-4H-pyrido[3,2-a]phenoxazine-3-carboxylate;Pirenoxine sodium;1-Hydroxy-5-oxo-5H-pyrido(3,2-a)phenoxazine-3-carboxylic acid sodium salt;Pirenoxine sodium salt;Sodium 1-hydroxy-5-oxo-5H-pyrido(3,2-a)phenoxazine-3-carboxylate;

 

5H-Pyrido[3,2-a]phenoxazine-3-carboxylicacid, 1-hydroxy-5-oxo-, sodium salt (1:1) Specification

The 5H-Pyrido[3,2-a]phenoxazine-3-carboxylicacid, 1-hydroxy-5-oxo-, sodium salt (1:1), with the CAS registry number 51410-30-1 and EINECS registry number 257-181-6, has the systematic name of sodium 1,5-dioxo-1,5-dihydro-4H-pyrido[3,2-a]phenoxazine-3-carboxylate. And the molecular formula of the chemical is C16H7N2NaO5.

The characteristics of 5H-Pyrido[3,2-a]phenoxazine-3-carboxylicacid, 1-hydroxy-5-oxo-, sodium salt (1:1) are as followings: (1)ACD/LogP: -0.91; (2)# of Rule of 5 Violations: 0 ; (3)#H bond acceptors: 7; (4)#H bond donors: 2; (5)#Freely Rotating Bonds: 1; (6)Polar Surface Area: 96.27 Å2; (7)Flash Point: 265.7 °C; (8)Enthalpy of Vaporization: 82.93 kJ/mol; (9)Boiling Point: 515.8 °C at 760 mmHg; (10)Vapour Pressure: 1.83E-11 mmHg at 25°C.

Addtionally, the following datas could be converted into the molecular structure:
(1)SMILES: [Na+].[O-]C(=O)\C3=C\C(=O)C=2\C1=N\c4c(O/C1=C/C(=O)C=2N3)cccc4
(2)InChI: InChI=1/C16H8N2O5.Na/c19-9-5-8(16(21)22)18-14-10(20)6-12-15(13(9)14)17-7-3-1-2-4-11(7)23-12;/h1-6H,(H,18,19)(H,21,22);/q;+1/p-1
(3)InChIKey: HDQXPMXHXZNPKE-REWHXWOFAD

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 2120mg/kg (2120mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: ANTIPSYCHOTIC
Oyo Yakuri. Pharmacometrics. Vol. 8, Pg. 911, 1974.
mouse LD50 oral > 10gm/kg (10000mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: ANTIPSYCHOTIC

LIVER: OTHER CHANGES
Oyo Yakuri. Pharmacometrics. Vol. 8, Pg. 911, 1974.
mouse LD50 subcutaneous > 5gm/kg (5000mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

LIVER: OTHER CHANGES

BEHAVIORAL: ANTIPSYCHOTIC
Oyo Yakuri. Pharmacometrics. Vol. 8, Pg. 911, 1974.
rat LD50 intraperitoneal 1460mg/kg (1460mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: ANTIPSYCHOTIC
Oyo Yakuri. Pharmacometrics. Vol. 8, Pg. 911, 1974.
rat LD50 oral > 10gm/kg (10000mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: ANTIPSYCHOTIC

LIVER: OTHER CHANGES
Oyo Yakuri. Pharmacometrics. Vol. 8, Pg. 911, 1974.
rat LD50 subcutaneous > 5gm/kg (5000mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: ANTIPSYCHOTIC

LIVER: OTHER CHANGES
Oyo Yakuri. Pharmacometrics. Vol. 8, Pg. 911, 1974.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 51410-30-1